THE NUCLEAR RECEPTOR LRH-1 IS A THERAPEUTIC TARGET FOR INFLAMMATORY BOWEL DISEASE (IBD)

被引:0
|
作者
Wang, Hongtao
Wang, Guohui
Moore, David D.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1881
引用
收藏
页码:S647 / S648
页数:2
相关论文
共 50 条
  • [31] Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation
    Benod, Cindy
    Vinogradova, Maia V.
    Jouravel, Natalia
    Kim, Grace E.
    Fletterick, Robert J.
    Sablin, Elena P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (41) : 16927 - 16931
  • [32] Another One Bites the Gut: Nuclear Receptor LRH-1 in Intestinal Regeneration and Cancer
    Zerlotin, Roberta
    Arconzo, Maria
    Piccinin, Elena
    Moschetta, Antonio
    CANCERS, 2021, 13 (04) : 1 - 17
  • [33] LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival
    James R. Bayrer
    Hongtao Wang
    Roy Nattiv
    Miyuki Suzawa
    Hazel S. Escusa
    Robert J. Fletterick
    Ophir D. Klein
    David D. Moore
    Holly A. Ingraham
    Nature Communications, 9
  • [34] LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival
    Bayrer, James R.
    Wang, Hongtao
    Nattiv, Roy
    Suzawa, Miyuki
    Escusa, Hazel S.
    Fletterick, Robert J.
    Klein, Ophir D.
    Moore, David D.
    Ingraham, Holly A.
    NATURE COMMUNICATIONS, 2018, 9
  • [35] The nuclear receptor LRH-1 discriminates between ligands using distinct allosteric signaling circuits
    Mays, Suzanne G.
    Hercules, David
    Ortlund, Eric A.
    Okafor, C. Denise
    PROTEIN SCIENCE, 2023, 32 (10)
  • [36] Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease
    Yang, Wen-sheng
    Wang, Jing-lin
    Wu, Wei
    Wang, Guang-fei
    Yan, Jun
    Liu, Qing
    Wu, Xiao-yan
    Zhou, Qing-tong
    Yang, De-hua
    Wang, Ming-Wei
    Li, Zhi-ping
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (01) : 19 - 31
  • [37] Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease
    Wen-sheng Yang
    Jing-lin Wang
    Wei Wu
    Guang-fei Wang
    Jun Yan
    Qing Liu
    Xiao-yan Wu
    Qing-tong Zhou
    De-hua Yang
    Ming-Wei Wang
    Zhi-ping Li
    Acta Pharmacologica Sinica, 2023, 44 : 19 - 31
  • [38] Differential Modulation of Nuclear Receptor LRH-1 throughTargeting Buried and Surface Regions of the Binding Pocket
    Cato, Michael L.
    Cornelison, Jeffery L.
    Spurlin, Racheal M.
    Courouble, Valentine V.
    Patel, Anamika B.
    Flynn, Autumn R.
    Johnson, Alyssa M.
    Okafor, C. Denise
    Frank, Filipp
    D'Agostino, Emma H.
    Griffin, Patrick R.
    Jui, Nathan T.
    Ortlund, Eric A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (09) : 6888 - 6902
  • [39] THE NUCLEAR RECEPTOR LRH-1 IS A KEY REGULATOR OF THE HEPATIC METHYL-POOL AND PHOSPHATIDYLCHOLINE METABOLISM
    Wagner, M.
    Mamrosh, J. L.
    Wooton-Kee, R.
    Lee, J. M.
    Xiao, R.
    Putluri, N.
    Stahlman, M.
    Boren, J.
    Sreekumar, A.
    Moore, D. D.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S157 - S157
  • [40] The nuclear receptor LRH-1 critically regulates extra-adrenal glucocorticoid synthesis in the intestine
    Mueller, Matthias
    Cima, Igor
    Noti, Mario
    Fuhrer, Andrea
    Jakob, Sabine
    Dubuquoy, Laurent
    Schoonjans, Kristina
    Brunner, Thomas
    JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (09): : 2057 - 2062